FDA Adds Blood Clot Risk Data To Birth Control Labels
The U.S. Food and Drug Administration has concluded birth control pills containing drospirenone may be associated with a higher risk of blood clots, and will include information from recent studies examining...To view the full article, register now.
Already a subscriber? Click here to view full article